{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:27:20Z","timestamp":1786980440738,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00894-020-04495-1","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T09:03:48Z","timestamp":1597136628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["In silico screening of GABA aminotransferase inhibitors from the constituents of Valeriana officinalis by molecular docking and molecular dynamics simulation study"],"prefix":"10.1007","volume":"26","author":[{"given":"Jin-Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuno","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1984-3545","authenticated-orcid":false,"given":"Wanjoo","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"4495_CR1","first-page":"705","volume":"186","author":"EG McGeer","year":"1984","unstructured":"McGeer EG, McGeer PL, Thompson S (1984) Glutamine, glutamate, and GABA in the central nervous system. FEBS Lett 186:705","journal-title":"FEBS Lett"},{"issue":"5","key":"4495_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0021-9258(19)77353-0","volume":"233","author":"CF Baxter","year":"1958","unstructured":"Baxter CF, Roberts E (1958) The gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase of beef brain. J Biol Chem 233(5):1135\u20131139","journal-title":"J Biol Chem"},{"issue":"2","key":"4495_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0006-8993(81)90539-4","volume":"206","author":"RA Bakay","year":"1981","unstructured":"Bakay RA, Harris AB (1981) Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci. Brain Res 206(2):387\u2013404. https:\/\/doi.org\/10.1016\/0006-8993(81)90539-4","journal-title":"Brain Res"},{"issue":"2","key":"4495_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1471-4159.1983.tb04761.x","volume":"41","author":"J Butterworth","year":"1983","unstructured":"Butterworth J, Yates CM, Simpson J (1983) Phosphate-activated glutaminase in relation to Huntington\u2019s disease and agonal state. J Neurochem 41(2):440\u2013447. https:\/\/doi.org\/10.1111\/j.1471-4159.1983.tb04761.x","journal-title":"J Neurochem"},{"issue":"3","key":"4495_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1254\/jjp.48.331","volume":"48","author":"N Nishino","year":"1988","unstructured":"Nishino N, Fujiwara H, Noguchi-Kuno SA, Tanaka C (1988) GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson\u2019s disease. Jpn J Pharmacol 48(3):331\u2013339. https:\/\/doi.org\/10.1254\/jjp.48.331","journal-title":"Jpn J Pharmacol"},{"issue":"6","key":"4495_CR6","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1248\/cpb.38.1748","volume":"38","author":"T Aoyagi","year":"1990","unstructured":"Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, Takeuchi T, Takahashi H, Hirokawa K, Tsumita T (1990) Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer\u2019s disease. Chem Pharm Bull (Tokyo) 38(6):1748\u20131749. https:\/\/doi.org\/10.1248\/cpb.38.1748","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"5966","key":"4495_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/309347a0","volume":"309","author":"LM Gunne","year":"1984","unstructured":"Gunne LM, Haggstrom JE, Sjoquist B (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309(5966):347\u2013349. https:\/\/doi.org\/10.1038\/309347a0","journal-title":"Nature"},{"issue":"4","key":"4495_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ajhp\/57.4.328","volume":"57","author":"SL Plushner","year":"2000","unstructured":"Plushner SL (2000) Valerian: Valeriana officinalis. Am J Health Syst Pharm 57(4):328, 333, 335. https:\/\/doi.org\/10.1093\/ajhp\/57.4.328","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"4495_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0378-8741(88)90123-7","volume":"22","author":"PJ Houghton","year":"1988","unstructured":"Houghton PJ (1988) The biological activity of valerian and related plants. J Ethnopharmacol 22(2):121\u2013142. https:\/\/doi.org\/10.1016\/0378-8741(88)90123-7","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"4495_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1139\/Y07-083","volume":"85","author":"R Awad","year":"2007","unstructured":"Awad R, Levac D, Cybulska P, Merali Z, Trudeau VL, Arnason JT (2007) Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system. Can J Physiol Pharmacol 85(9):933\u2013942. https:\/\/doi.org\/10.1139\/Y07-083","journal-title":"Can J Physiol Pharmacol"},{"issue":"11","key":"4495_CR11","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1023\/a:1022576405534","volume":"24","author":"JG Ortiz","year":"1999","unstructured":"Ortiz JG, Nieves-Natal J, Chavez P (1999) Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem Res 24(11):1373\u20131378. https:\/\/doi.org\/10.1023\/a:1022576405534","journal-title":"Neurochem Res"},{"issue":"2","key":"4495_CR12","first-page":"220","volume":"327","author":"MS Santos","year":"1994","unstructured":"Santos MS, Ferreira F, Cunha AP, Carvalho AP, Ribeiro CF, Macedo T (1994) Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier. Arch Int Pharmacodyn Ther 327(2):220\u2013231","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"4495_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/1472-6882-14-267","volume":"14","author":"A Becker","year":"2014","unstructured":"Becker A, Felgentreff F, Schroder H, Meier B, Brattstrom A (2014) The anxiolytic effects of a valerian extract is based on valerenic acid. BMC Complement Altern Med 14:267. https:\/\/doi.org\/10.1186\/1472-6882-14-267","journal-title":"BMC Complement Altern Med"},{"issue":"3","key":"4495_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1124\/jpet.116.232983","volume":"357","author":"S Khom","year":"2016","unstructured":"Khom S, Hintersteiner J, Luger D, Haider M, Pototschnig G, Mihovilovic MD, Schwarzer C, Hering S (2016) Analysis of beta-subunit-dependent GABAA receptor modulation and behavioral effects of valerenic acid derivatives. J Pharmacol Exp Ther 357(3):580\u2013590. https:\/\/doi.org\/10.1124\/jpet.116.232983","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"4495_CR15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1016-8478(23)13118-9","volume":"18","author":"DW Kim","year":"2004","unstructured":"Kim DW, Yoon CS, Eum WS, Lee BR, An JJ, Lee SH, Lee SR, Ahn JY, Kwon OS, Kang TC, Won MH, Cho SW, Lee KS, Park J, Choi SY (2004) Site-directed mutagenesis of human brain GABA transaminase: lysine-357 is involved in cofactor binding at the active site. Mol Cell 18(3):314\u2013319","journal-title":"Mol Cell"},{"issue":"1","key":"4495_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1074\/jbc.M305884200","volume":"279","author":"P Storici","year":"2004","unstructured":"Storici P, De Biase D, Bossa F, Bruno S, Mozzarelli A, Peneff C, Silverman RB, Schirmer T (2004) Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5\u2032-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin. J Biol Chem 279(1):363\u2013373. https:\/\/doi.org\/10.1074\/jbc.M305884200","journal-title":"J Biol Chem"},{"issue":"27","key":"4495_CR17","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1021\/bi990478j","volume":"38","author":"P Storici","year":"1999","unstructured":"Storici P, Capitani G, De Biase D, Moser M, John RA, Jansonius JN, Schirmer T (1999) Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy. Biochemistry 38(27):8628\u20138634. https:\/\/doi.org\/10.1021\/bi990478j","journal-title":"Biochemistry"},{"issue":"5","key":"4495_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1471-4159.1977.tb10721.x","volume":"29","author":"MJ Jung","year":"1977","unstructured":"Jung MJ, Lippert B, Metcalf BW, Bohlen P, Schechter PJ (1977) gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 29(5):797\u2013802. https:\/\/doi.org\/10.1111\/j.1471-4159.1977.tb10721.x","journal-title":"J Neurochem"},{"issue":"1","key":"4495_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1471-4159.1975.tb07642.x","volume":"24","author":"GA Johnston","year":"1975","unstructured":"Johnston GA, Curtis DR, Beart PM, Game CJ, McCulloch RM, Twitchin B (1975) Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J Neurochem 24(1):157\u2013160. https:\/\/doi.org\/10.1111\/j.1471-4159.1975.tb07642.x","journal-title":"J Neurochem"},{"issue":"2","key":"4495_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0006-8993(74)90147-4","volume":"66","author":"F Schon","year":"1974","unstructured":"Schon F, Kelly JS (1974) The characterisation of [3H]GABA uptake into the satellite glial cells of rat sensory ganglia. Brain Res 66(2):289\u2013900","journal-title":"Brain Res"},{"issue":"4","key":"4495_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.2042-7158.1977.tb11297.x","volume":"29","author":"GA Johnston","year":"1977","unstructured":"Johnston GA, Stephanson AL, Twitchin B (1977) Piperazic acid and related compounds as inhibitors of GABA uptake in rat brain slices. J Pharm Pharmacol 29(4):240\u2013241. https:\/\/doi.org\/10.1111\/j.2042-7158.1977.tb11297.x","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"4495_CR22","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3891\/acta.chem.scand.26-1298","volume":"26","author":"L Brehm","year":"1972","unstructured":"Brehm L, Hjeds H, Krogsgaard-Larsen P (1972) The structure of muscimol, a GABA analogue of restricted conformation. Acta Chem Scand 26(3):1298\u20131299. https:\/\/doi.org\/10.3891\/acta.chem.scand.26-1298","journal-title":"Acta Chem Scand"},{"issue":"5615","key":"4495_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/268053a0","volume":"268","author":"P Krogsgaard-Larsen","year":"1977","unstructured":"Krogsgaard-Larsen P, Johnston GA, Lodge D, Curtis DR (1977) A new class of GABA agonist. Nature 268(5615):53\u201355. https:\/\/doi.org\/10.1038\/268053a0","journal-title":"Nature"},{"issue":"46","key":"4495_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/newbio234080a0","volume":"234","author":"PM Beart","year":"1971","unstructured":"Beart PM, Curtis DR, Johnston GA (1971) 4-aminotetrolic acid: new conformational-restricted analogue of -aminobutyric acid. Nat New Biol 234(46):80\u201381. https:\/\/doi.org\/10.1038\/newbio234080a0","journal-title":"Nat New Biol"},{"key":"4495_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0076-6879(95)49038-8","volume":"249","author":"RB Silverman","year":"1995","unstructured":"Silverman RB (1995) Mechanism-based enzyme inactivators. Methods Enzymol 249:240\u2013283. https:\/\/doi.org\/10.1016\/0076-6879(95)49038-8","journal-title":"Methods Enzymol"},{"issue":"11","key":"4495_CR26","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1021\/jm00131a001","volume":"32","author":"SM Nanavati","year":"1989","unstructured":"Nanavati SM, Silverman RB (1989) Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators. J Med Chem 32(11):2413\u20132421. https:\/\/doi.org\/10.1021\/jm00131a001","journal-title":"J Med Chem"},{"issue":"3","key":"4495_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1432-1033.1977.tb11410.x","volume":"74","author":"B Lippert","year":"1977","unstructured":"Lippert B, Metcalf BW, Jung MJ, Casara P (1977) 4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur J Biochem 74(3):441\u2013445. https:\/\/doi.org\/10.1111\/j.1432-1033.1977.tb11410.x","journal-title":"Eur J Biochem"},{"issue":"12","key":"4495_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1345\/aph.18376","volume":"33","author":"BE Gidal","year":"1999","unstructured":"Gidal BE, Privitera MD, Sheth RD, Gilman JT (1999) Vigabatrin: a novel therapy for seizure disorders. Ann Pharmacother 33(12):1277\u20131286. https:\/\/doi.org\/10.1345\/aph.18376","journal-title":"Ann Pharmacother"},{"issue":"3","key":"4495_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2165\/00023210-200115030-00005","volume":"15","author":"R Kalviainen","year":"2001","unstructured":"Kalviainen R, Nousiainen I (2001) Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs 15(3):217\u2013230. https:\/\/doi.org\/10.2165\/00023210-200115030-00005","journal-title":"CNS Drugs"},{"issue":"1","key":"4495_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/1871524916666160104143108","volume":"17","author":"B Mathew","year":"2016","unstructured":"Mathew B, Mathew GE, Suresh J, Usman D, Shiva Subramanyan PN, Safna KF (2016) Ligand based drug design of new heterocyclic imines of GABA analogues: a molecular docking approach for the discovery of new GABA-AT inhibitors. Cent Nerv Syst Agents Med Chem 17(1):58\u201363","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"4495_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/0361-9230(80)90094-5","volume":"5","author":"B Meldrum","year":"1980","unstructured":"Meldrum B (1980) Mechanism of action of valproate. Brain Res Bull 5:579\u2013584","journal-title":"Brain Res Bull"},{"key":"4495_CR32","unstructured":"(2009) Chemical intormation review document for valerian"},{"issue":"W1","key":"4495_CR33","doi-asserted-by":"publisher","first-page":"W636","DOI":"10.1093\/nar\/gkz268","volume":"47","author":"F Madeira","year":"2019","unstructured":"Madeira F, Park YM, Lee J, Buso N, Gur T, Madhusoodanan N, Basutkar P, Tivey ARN, Potter SC, Finn RD, Lopez R (2019) The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res 47(W1):W636\u2013W641. https:\/\/doi.org\/10.1093\/nar\/gkz268","journal-title":"Nucleic Acids Res"},{"key":"4495_CR34","unstructured":"Accelrys Software Inc DISCOVERY STUDIO. Accelrys, San Diego, CA"},{"issue":"12","key":"4495_CR35","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/s0969-2126(96)00147-5","volume":"4","author":"GJ Kleywegt","year":"1996","unstructured":"Kleywegt GJ, Jones TA (1996) Phi\/psi-chology: Ramachandran revisited. Structure 4(12):1395\u20131400. https:\/\/doi.org\/10.1016\/s0969-2126(96)00147-5","journal-title":"Structure"},{"key":"4495_CR36","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2:1511\u20131519","journal-title":"Protein Sci"},{"issue":"13","key":"4495_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera--a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"4495_CR38","doi-asserted-by":"publisher","first-page":"S1267","DOI":"10.1016\/j.arabjc.2013.03.007","volume":"10","author":"H Iftikhar","year":"2017","unstructured":"Iftikhar H, Batool S, Deep A, Narasimhan B, Sharma PC, Malhotra M (2017) In silico analysis of the inhibitory activities of GABA derivatives on 4-aminobutyrate transaminase. Arab J Chem 10:S1267\u2013S1275. https:\/\/doi.org\/10.1016\/j.arabjc.2013.03.007","journal-title":"Arab J Chem"},{"issue":"2","key":"4495_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8(2):127\u2013134. https:\/\/doi.org\/10.1093\/protein\/8.2.127","journal-title":"Protein Eng"},{"issue":"1\u20133","key":"4495_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","volume":"91","author":"HJC Berendsen","year":"1995","unstructured":"Berendsen HJC, van der Spoel D, van Drunen R (1995) GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun 91(1\u20133):43\u201356","journal-title":"Comput Phys Commun"},{"key":"4495_CR41","unstructured":"David van der Spoel, E. Lindahl, Berk Hess, Buuren ARv, Apol E, Meulenhoff PJ, Tieleman DP, Sijbers ALTM, Feenstra KA, Drunen RV, Berendsen HJC (2006) GROMACS user manual version 3.3 department of biophysical chemistry. University of Groningen Nijenborgh 4,9747"},{"issue":"11","key":"4495_CR42","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo S, Kim T, Iyer VG, Im W (2008) CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem 29(11):1859\u20131865. https:\/\/doi.org\/10.1002\/jcc.20945","journal-title":"J Comput Chem"},{"key":"4495_CR43","doi-asserted-by":"publisher","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(1):33\u201338, 27\u201338 https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","DOI":"10.1016\/0263-7855(96)00018-5"},{"issue":"3","key":"4495_CR44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejbas.2018.05.008","volume":"5","author":"S Vijayakumar","year":"2018","unstructured":"Vijayakumar S, Kasthuri G, Prabhu S, Manogar P, Parameswari N (2018) Screening and identification of novel inhibitors against human 4-aminobutyrate-aminotransferase: a computational approach. Egypt J Basic Appl Sci 5(3):210\u2013219","journal-title":"Egypt J Basic Appl Sci"},{"issue":"1","key":"4495_CR45","doi-asserted-by":"publisher","first-page":"e85827","DOI":"10.1371\/journal.pone.0085827","volume":"9","author":"Y Lee","year":"2014","unstructured":"Lee Y, Kim S, Kim JY, Arooj M, Kim S, Hwang S, Kim BW, Park KH, Lee KW (2014) Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of alpha-glucosidase inhibitors. PLoS One 9(1):e85827. https:\/\/doi.org\/10.1371\/journal.pone.0085827","journal-title":"PLoS One"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-020-04495-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-020-04495-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-020-04495-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T12:59:04Z","timestamp":1723381144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-020-04495-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["4495"],"URL":"https:\/\/doi.org\/10.1007\/s00894-020-04495-1","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}